A preparation method and kit for low-copy endotoxin-free plasmid
Through the combination of bacterial culture and specific reagents, the efficient preparation and endotoxin removal of low-copy plasmids are solved, and the preparation of high-quality low-copy de-endotoxin plasmids is achieved, which is suitable for 20μg-10mg plasmid production.
Patent Information
- Application Number
- CN202411067556.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-08-06
AI Technical Summary
The prior art is difficult to effectively prepare low-copy endotoxin de-plasmids, especially when facing plasmids with polyadenylate sequences or low-copy replicons, the extraction amount is low, the endotoxin removal effect is poor, the genome contamination and abnormal plasmid purity are , cannot be used directly for the production of high-quality low-copy plasmids.
A low-copy de-endotoxin plasmid preparation method, including bacterial culture, bacterial lysis, filtration, ion exchange chromatography and isopropanol rinsing, through specific reagents and devices (such as bacterial lysis reagents, endotoxins Removal reagents, ion exchange chromatography gravity column) achieve efficient extraction of plasmids and endotoxin removal.
The efficient preparation of low-copy plasmids is achieved, with normal optical density of the plasmid and low endotoxin level. It is suitable for the preparation of 20μg-10mg plasmids, solving the problems of low extraction amount and poor endotoxin removal effect in the prior art.
Smart Images

Figure CN118620885B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a preparation method and a kit for a low-copy endotoxin-free plasmid, which are particularly suitable for preparing 20 μg-10 mg of a low-copy endotoxin-free plasmid and belong to the field of biotechnology. Background Art
[0002] In CGT cell gene therapy technology, plasmids are an important raw material. Among them, plasmids with polyadenylation (poly(A)) sequences or plasmids with other low-copy replicons usually have extremely low yields due to their stability requiring low-temperature culture or due to their plasmid characteristics, and they also have a series of problems such as difficulty in purification or excessive endotoxin.
[0003] Plasmids used in cell gene therapy technology need to control endotoxins below 100EU / mg. Currently, commercial technical means on the market include endotoxin-free plasmid preparation kits, which usually use anion exchange chromatography gravity columns, or combine endotoxins with rinse fluid and filter them out. This technical means can normally obtain endotoxin-free plasmids when the plasmid copy number is high or normal. However, when faced with plasmids with polyadenylation (poly(A)) sequences or plasmids with other low-copy replicons, there will be extremely low extraction yields, drastically reduced endotoxin removal effects, genomic contamination, plasmid A260 / 280 and A260 / 230 abnormalities, etc., and they cannot be directly used to produce high-quality low-copy plasmids.
[0004] After searching, it was found that the invention patent application with application number 202310851243.5 and application publication number CN116814612A disclosed a low-endotoxin plasmid extraction kit and an extraction method thereof. However, the prior art patents represented by this patent did not pay attention to the above-mentioned technical problems existing in the preparation of low-copy endotoxin-free plasmids, and cannot be directly applied to the preparation of low-copy endotoxin-free plasmids. Summary of the invention
[0005] The main purpose of the present invention is to overcome the problems existing in the prior art and provide a method for preparing a low-copy endotoxin-free plasmid, wherein the obtained low-copy plasmid has normal OD, high preparation volume, and low endotoxin level, and is particularly suitable for preparing 20 μg-10 mg low-copy endotoxin-free plasmid. At the same time, a corresponding kit is also provided.
[0006] The technical solution of the present invention to solve the technical problem is as follows:
[0007] A method for preparing a low-copy endotoxin-free plasmid comprises the following steps:
[0008] In the first step, bacteria containing the target low-copy plasmid are cultured to obtain bacterial culture fluid, and bacterial cells are collected by centrifugation.
[0009] Step 2: Weigh the weight of the bacteria, and determine the volumes of the bacteria lysis reagents L1, L2, and L3 according to the weight-to-volume ratio of bacteria: bacteria lysis reagent L1: bacteria lysis reagent L2: bacteria lysis reagent L3 = 1±0.1g:15ml:25ml:25ml; add the bacteria lysis reagent L1 to the bacteria and resuspend; add the bacteria lysis reagent L2, continue mixing until the mixed liquid is light yellow and translucent, and let it stand; add the bacteria lysis reagent L3, continue mixing until the mixed sample is a light yellow liquid with egg drop-shaped floating solids; wherein, the bacteria lysis reagent L1 is a solution composed of Tris-HCl, EDTA, glucose, RNaseA and water; the bacteria lysis reagent L2 is a solution composed of NaOH, SDS and water; the bacteria lysis reagent L3 is a solution composed of potassium acetate, acetic acid and water.
[0010] The third step is to filter the mixture obtained in the second step using a lysate filtering device to obtain a clear and transparent lysate; the lysate filtering device is provided with a filter membrane or filter with a pore size of 0.45-10 μm.
[0011] Step 4: Add endotoxin removal reagent LER to the lysate obtained in step 3, and the volume ratio of endotoxin removal reagent LER: lysate is 1±0.1:50; mix well and place in an ice bath until the solution is clear; wherein, endotoxin removal reagent LER is a solution composed of Triton X-114 and ethanol in a volume ratio of 1±0.1:1.
[0012] Step 5: Use a gravity chromatography column and fill it with ion exchange chromatography filler to obtain a gravity column; use 8-15 times the filler volume of ion exchange chromatography gravity column balance reagent LEB to balance the gravity column, and empty it naturally by gravity; wherein, the ion exchange chromatography gravity column balance reagent LEB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1.
[0013] Step 6. Transfer all the solutions obtained in step 4 into the gravity column in batches and drain them naturally by gravity. Use 8-15 times the volume of the filler volume of impurity cleaning reagent LWB to clean the gravity column and drain them naturally by gravity. Add endotoxin removal reagent LER to the impurity cleaning reagent LWB in advance, and the volume ratio is endotoxin removal reagent LER: impurity cleaning reagent LWB = 1±0.1:100. Mix well and place in an ice bath for use. Wherein, the impurity cleaning reagent LWB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1.
[0014] Step 7: Add 1.2-2 times the volume of the filler material of the plasmid elution reagent LEN to the gravity column for elution, and collect the eluate; wherein the plasmid elution reagent LEN is a solution composed of NaCl, MOPS, isopropanol and water, and the pH of the solution is 7.2±0.1.
[0015] Step 8. Add isopropanol to the eluent, and the volume ratio of eluent: isopropanol is 1±0.1:0.7, mix well and centrifuge; remove the supernatant, add 70±1% ethanol to rinse the precipitate, and the volume ratio of eluent: 70±1% ethanol is 1:1-2, and centrifuge.
[0016] Step 9: Remove the supernatant, air-dry naturally until the edge of the precipitate becomes transparent, add a predetermined volume of endotoxin-free plasmid solvent to dissolve, and obtain a low-copy endotoxin-free plasmid solution.
[0017] This method has resuspension, lysis, neutralization, clarification and washing as main steps, and uses specific reagents in each step, such as bacterial lysis reagent L1, bacterial lysis reagent L2, bacterial lysis reagent L3, etc., and specific consumables, such as gravity columns, etc., so that the technical effect of normal OD, high preparation volume and low endotoxin level can be achieved for low copy plasmids.
[0018] Preferably, in the first step, the bacteria is Escherichia coli; the target low-copy plasmid contains a polyadenylation sequence and / or a low-copy replicon; and the centrifugation conditions are 8000-9000 rpm, 5-6 min, and 3° C.-4° C.
[0019] Preferably, in the first step, the target low copy plasmid also contains an antibiotic resistance gene, and a culture medium containing corresponding antibiotics is used for culturing. The culture medium is a plant-derived rich culture medium, and its components are: yeast extract (YE) 15g / L, soy peptone (Soytone) 25g / L, MgSO40.3g / L, NaCl 5g / L, glycerol (Glycerol) 10g / L, Na2HPO4·12H2O 7g / L, KH2PO42g / L, 0.05g / L corresponding antibiotics are added, and the balance is water.
[0020] Preferably, the specific process of the first step is: pick a single colony of Escherichia coli containing the target low-copy plasmid and inoculate it into 3~6 ml of a plant-derived rich culture medium containing the corresponding antibiotics, culture it at 30℃±1℃ 200±20rpm until OD600 is 2±0.2, inoculate it into 400~500 ml of a plant-derived rich culture medium containing the corresponding antibiotics at a ratio of 1‰, culture it at 30℃±1℃ 200±20rpm for 12~24h to obtain a bacterial culture solution; centrifuge at 8000~9000rpm, 5~6min, 3℃~4℃ to collect the Escherichia coli cells.
[0021] By adopting the above preferred scheme, the specific technical details of the first step can be further optimized.
[0022] Preferably, in the second step, the continuous mixing is performed by inversion mixing, or by continuous stirring at 30-40 rpm.
[0023] By adopting the above preferred scheme, the specific technical details of the second step can be further optimized.
[0024] Preferably, in the third step, the lysate filtering device comprises a small amount of lysate filtering device, a medium amount of lysate filtering device, and a large amount of lysate filtering device.
[0025] The small amount lysate filtering device includes a 30ml syringe and a matching piston rod. A 1μm syringe filter connected to the syringe outlet is arranged on the outside of the syringe. A 50μm pore size PP material baffle, a 5μm pore size PP material filter membrane, a 10μm pore size PP material filter membrane, and a 50μm pore size PP material baffle are arranged in sequence near the outlet of the syringe. Among them, the 5μm pore size PP material filter membrane is closer to the syringe outlet than the 10μm pore size PP material filter membrane. The diameter of the PP material baffle is 23mm, and the diameter of the PP material filter membrane is 22.5mm.
[0026] The medium-volume lysate filtering device comprises a diaphragm vacuum pump and a 500ml vacuum filter, wherein a PES membrane with a pore size of 0.45 μm is arranged in the vacuum filter.
[0027] The bulk lysate filtration device includes a PP capsule filter with a pore size of 1 μm, a peristaltic pump and a pressure gauge.
[0028] When the volume of the mixture obtained in the second step is less than 200 ml, a small amount of lysate filtering device is used; when 200 ml ≤ the volume of the mixture obtained in the second step ≤ 500 ml, a medium amount of lysate filtering device is used; when the volume of the mixture obtained in the second step is greater than 500 ml, a large amount of lysate filtering device is used.
[0029] By adopting the above preferred scheme, the lysate filtering device in the third step can be further optimized.
[0030] Preferably, in the fourth step, mix as needed during ice bathing; if the solution cannot be clarified by ice bathing, the solution is centrifuged at 15,000-16,000 × g, 10-20 min, 3°C-4°C, the supernatant is taken and endotoxin removal reagent LER is added, the volume ratio of endotoxin removal reagent LER added here: the lysate obtained in the third step is 1±0.1:50, and the mixture is mixed and set aside.
[0031] By adopting the above preferred scheme, the specific technical details of the fourth step can be further optimized.
[0032] Preferably, in the fifth step, the ion exchange chromatography filler is a weakly basic anion exchange resin (e.g., Ultrapure 500, Qiagen); the filling volume of the ion exchange chromatography filler is determined according to the amount of plasmid preparation, plasmid preparation amount: filling volume of ion exchange chromatography filler = 100~180μg: 1ml; the specifications of the gravity chromatography column match the filling volume of the ion exchange chromatography filler.
[0033] By adopting the above preferred scheme, the specific technical details of the fifth step can be further optimized.
[0034] Preferably, in the eighth step, isopropanol and 70±1% ethanol are pre-cooled to preset temperatures for use, respectively, and the preset temperature is room temperature or 3°C~4°C; the mixing after adding isopropanol is performed by inversion mixing; the centrifugation conditions are 15000~16000×g, 30~40min, 3°C~4°C.
[0035] By adopting the above preferred scheme, the specific technical details of the eighth step can be further optimized.
[0036] Preferably, in the second step, in the bacterial lysis reagent L1, the molar concentration of Tris-HCl is 50±5mM, the molar concentration of EDTA is 10±1mM, the molar concentration of glucose is 25±2mM, and the concentration of RNaseA is 0.15±0.01g / L; in the bacterial lysis reagent L2, the molar concentration of NaOH is 0.2±0.02M, and the concentration of SDS is 1±0.1%; in the bacterial lysis reagent L3, the molar concentration of potassium acetate is 3±0.3M, and acetic acid is used to adjust the pH of the solution to 5.2~5.5.
[0037] In the fifth step, in the ion exchange chromatography gravity column balance reagent LEB, the molar concentration of NaCl is 1±0.1 M, the molar concentration of MOPS is 50±5 mM, the volume concentration of isopropanol is 15±1%, and the volume concentration of Triton X-114 is 0.5±0.1%.
[0038] In the sixth step, in the impurity cleaning reagent LWB, the molar concentration of NaCl is 750±50 mM, the molar concentration of MOPS is 50±5 mM, the concentration of isopropanol is 15±1%, and the concentration of Triton X-114 is 0.15±0.02%.
[0039] In the seventh step, in the plasmid elution reagent LEN, the molar concentration of NaCl is 1.6±0.1 M, the molar concentration of MOPS is 50±5 mM, and the concentration of isopropanol is 15±1%.
[0040] In the ninth step, the endotoxin-free plasmid solvent is endotoxin-free ddH2O or endotoxin-free TE buffer.
[0041] Preferably, the bacterial lysis reagent L1 and the bacterial lysis reagent L3 are stored at 3°C~4°C in advance, and the bacterial lysis reagent L2, the endotoxin removal reagent LER, the ion exchange chromatography gravity column balance reagent LEB, the impurity cleaning reagent LWB, the plasmid elution reagent LEN, and the endotoxin-free plasmid solvent are stored at room temperature for use.
[0042] By adopting the above preferred scheme, the specific technical details of the reagents used in each step can be further optimized.
[0043] The present invention also provides:
[0044] A kit for preparing a low-copy endotoxin-free plasmid, using the preparation method of the low-copy endotoxin-free plasmid described above as a use process, the kit comprises: a bacterial lysis reagent L1, a bacterial lysis reagent L2, a bacterial lysis reagent L3, an endotoxin removal reagent LER, an ion exchange chromatography gravity column balance reagent LEB, an impurity cleaning reagent LWB, a plasmid elution reagent LEN, a lysis solution filter, a gravity chromatography column, and an ion exchange chromatography filler.
[0045] Among them, the bacterial lysis reagent L1 is a solution composed of Tris-HCl, EDTA, glucose, RNaseA and water; the bacterial lysis reagent L2 is a solution composed of NaOH, SDS and water; the bacterial lysis reagent L3 is a solution composed of potassium acetate, acetic acid and water; the endotoxin removal reagent LER is a solution composed of Triton X-114 and ethanol in a volume ratio of 1±0.1:1; the ion exchange chromatography gravity column balance reagent LEB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; the impurity cleaning reagent LWB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; the plasmid elution reagent LEN is a solution composed of NaCl, MOPS, isopropanol and water, and the pH of the solution is 7.2±0.1; the lysis solution filtration device is provided with a filter membrane or filter with a pore size of 0.45~10μm.
[0046] This kit can be used to prepare low-copy plasmids and achieve the technical effects of normal OD, high preparation volume, and low endotoxin level.
[0047] Preferably, the lysate filtering device comprises a small amount lysate filtering device, a medium amount lysate filtering device, and a large amount lysate filtering device.
[0048] The small amount lysate filtering device includes a 30ml syringe and a matching piston rod. A 1μm syringe filter connected to the syringe outlet is arranged on the outside of the syringe. A 50μm pore size PP material baffle, a 5μm pore size PP material filter membrane, a 10μm pore size PP material filter membrane, and a 50μm pore size PP material baffle are arranged in sequence near the outlet of the syringe. Among them, the 5μm pore size PP material filter membrane is closer to the syringe outlet than the 10μm pore size PP material filter membrane. The diameter of the PP material baffle is 23mm, and the diameter of the PP material filter membrane is 22.5mm.
[0049] The medium-volume lysate filtering device comprises a diaphragm vacuum pump and a 500ml vacuum filter, wherein a PES membrane with a pore size of 0.45 μm is arranged in the vacuum filter.
[0050] The bulk lysate filtration device includes a PP capsule filter with a pore size of 1 μm, a peristaltic pump and a pressure gauge.
[0051] When the lysate volume is less than 200 ml, a small-volume lysate filtration device is used; when 200 ml ≤ lysate volume ≤ 500 ml, a medium-volume lysate filtration device is used; when the lysate volume is greater than 500 ml, a large-volume lysate filtration device is used.
[0052] Preferably, the ion exchange chromatography filler is a weakly basic anion exchange resin (e.g., Ultrapure 500, Qiagen). The filling volume of the ion exchange chromatography filler is determined according to the amount of plasmid preparation, plasmid preparation amount: filling volume of ion exchange chromatography filler = 100~180μg: 1ml; the specifications of the gravity chromatography column match the filling volume of the ion exchange chromatography filler.
[0053] Preferably, in the bacterial lysis reagent L1, the molar concentration of Tris-HCl is 50±5mM, the molar concentration of EDTA is 10±1mM, the molar concentration of glucose is 25±2mM, and the concentration of RNaseA is 0.15±0.01g / L; in the bacterial lysis reagent L2, the molar concentration of NaOH is 0.2±0.02M, and the concentration of SDS is 1±0.1%; in the bacterial lysis reagent L3, the molar concentration of potassium acetate is 3±0.3M, and acetic acid is used to adjust the pH of the solution to 5.2~5.5; in the ion exchange chromatography gravity column balance reagent LEB, the molar concentration of NaCl is 1±0.1M, the molar concentration of MOPS is 50±5mM, the volume concentration of isopropanol is 15±1%, and the volume concentration of Triton is 10±1%. The volume concentration of X-114 is 0.5±0.1%; in the impurity cleaning reagent LWB, the molar concentration of NaCl is 750±50mM, the molar concentration of MOPS is 50±5mM, the concentration of isopropanol is 15±1%, and the concentration of Triton X-114 is 0.15±0.02%; in the plasmid elution reagent LEN, the molar concentration of NaCl is 1.6±0.1M, the molar concentration of MOPS is 50±5mM, and the concentration of isopropanol is 15±1%.
[0054] By adopting the above preferred scheme, the specific technical details of the kit can be further optimized.
[0055] Compared with the prior art, the present invention is specifically aimed at the preparation of low-copy plasmids, achieving the technical effects of normal OD, high preparation volume, and low endotoxin level, and is particularly suitable for preparing 20μg-10mg low-copy endotoxin-free plasmids. BRIEF DESCRIPTION OF THE DRAWINGS
[0056] Figure 1 The figure is a result of plasmid electrophoresis detection of Examples 1 to 3 of the present invention. Wherein, M is a molecular weight standard (1000 bp DNA Marker), lane 1 is the sample of Example 1, lane 2 is the sample of Example 2, and lane 3 is the sample of Example 3.
[0057] Figure 2 The plasmid electrophoresis detection result diagram of Example 4 of the present invention is shown in FIG. Wherein, M is a molecular weight standard (5000 bp DNA Marker), lane 1 is a Q1 group sample, lane 2 is a Q2 group sample, and lane 3 is a L group sample. DETAILED DESCRIPTION
[0058] The present invention specifically implements a method for preparing a low-copy endotoxin-free plasmid, comprising the following steps:
[0059] In the first step, bacteria containing the target low-copy plasmid are cultured to obtain bacterial culture fluid, and bacterial cells are collected by centrifugation.
[0060] The bacteria is Escherichia coli; the target low-copy plasmid contains a polyadenylation sequence and / or a low-copy replicon; the target low-copy plasmid also contains an antibiotic resistance gene, and a culture medium containing corresponding antibiotics is used for culture. The culture medium is a plant-derived rich culture medium, and its components are: yeast extract (YE) 15g / L, soy peptone (Soytone) 25g / L, MgSO40.3g / L, NaCl 5g / L, glycerol (Glycerol) 10g / L, Na2HPO4·12H2O 7g / L, KH2PO42g / L, 0.05g / L corresponding antibiotics are added, and the remainder is water; the centrifugation conditions are 8000~9000rpm, 5~6min, 3℃~4℃.
[0061] The specific process of the first step is: pick a single colony of Escherichia coli containing the target low-copy plasmid and inoculate it into 3~6 ml of a plant-derived rich culture medium containing the corresponding antibiotics, culture it at 30℃±1℃ and 200±20rpm until OD600 is 2±0.2, inoculate it into 400~500 ml of a plant-derived rich culture medium containing the corresponding antibiotics at a ratio of 1‰, culture it at 30℃±1℃ and 200±20rpm for 12~24h to obtain a bacterial culture solution; centrifuge at 8000~9000rpm, 5~6min, and 3℃~4℃ to collect the Escherichia coli cells.
[0062] Step 2: Weigh the weight of the bacteria, and determine the volumes of bacterial lysis reagents L1, L2, and L3 according to the weight-to-volume ratio of bacteria: bacterial lysis reagent L1: bacterial lysis reagent L2: bacterial lysis reagent L3 = 1±0.1g:15ml:25ml:25ml; add bacterial lysis reagent L1 to the bacteria and resuspend; add bacterial lysis reagent L2 and continue mixing until the mixed liquid becomes light yellow and translucent, and let it stand; add bacterial lysis reagent L3 and continue mixing until the mixed sample becomes light yellow liquid with egg drop-shaped floating solids.
[0063] Among them, the bacterial lysis reagent L1 is a solution composed of Tris-HCl, EDTA, glucose, RNaseA and water, in which the molar concentration of Tris-HCl is 50±5mM, the molar concentration of EDTA is 10±1mM, the molar concentration of glucose is 25±2mM, and the concentration of RNaseA is 0.15±0.01g / L.
[0064] The bacterial lysis reagent L2 is a solution composed of NaOH, SDS and water, in which the molar concentration of NaOH is 0.2±0.02M and the concentration of SDS is 1±0.1%;
[0065] The bacterial cell lysis reagent L3 is a solution composed of potassium acetate, acetic acid and water. The molar concentration of potassium acetate in the solution is 3±0.3 M. Acetic acid is used to adjust the pH of the solution to 5.2-5.5.
[0066] When mixing continuously, mix by inversion or by continuous stirring at 30-40 rpm.
[0067] The third step is to filter the mixture obtained in the second step using a lysate filtering device to obtain a clear and transparent lysate; the lysate filtering device is provided with a filter membrane or filter with a pore size of 0.45-10 μm.
[0068] Among them, the lysate filtering device includes a small amount of lysate filtering device, a medium amount of lysate filtering device, and a large amount of lysate filtering device.
[0069] The small amount lysate filtering device includes a 30ml syringe and a matching piston rod. A 1μm syringe filter connected to the syringe outlet is arranged on the outside of the syringe. A 50μm pore size PP material baffle, a 5μm pore size PP material filter membrane, a 10μm pore size PP material filter membrane, and a 50μm pore size PP material baffle are arranged in sequence near the outlet of the syringe. Among them, the 5μm pore size PP material filter membrane is closer to the syringe outlet than the 10μm pore size PP material filter membrane. The diameter of the PP material baffle is 23mm, and the diameter of the PP material filter membrane is 22.5mm.
[0070] The medium-volume lysate filtering device comprises a diaphragm vacuum pump and a 500ml vacuum filter, wherein a PES membrane with a pore size of 0.45 μm is arranged in the vacuum filter.
[0071] The bulk lysate filtration device includes a PP capsule filter with a pore size of 1 μm, a peristaltic pump and a pressure gauge.
[0072] When the volume of the mixture obtained in the second step is less than 200 ml, a small amount of lysate filtering device is used; when 200 ml ≤ the volume of the mixture obtained in the second step ≤ 500 ml, a medium amount of lysate filtering device is used; when the volume of the mixture obtained in the second step is greater than 500 ml, a large amount of lysate filtering device is used.
[0073] Step 4: Add endotoxin removal reagent LER to the lysate obtained in step 3, and the volume ratio of endotoxin removal reagent LER: lysate is 1±0.1:50; mix well and place in an ice bath until the solution is clear.
[0074] The endotoxin removal reagent LER is a solution composed of Triton X-114 and ethanol in a volume ratio of 1±0.1:1.
[0075] Mix as needed during ice bath. If the ice bath cannot clarify the solution, centrifuge the solution at 15,000-16,000 × g, 10-20 min, 3°C-4°C, take the supernatant and add endotoxin removal reagent LER. The volume ratio of endotoxin removal reagent LER added here: the lysate obtained in the third step is 1±0.1:50. Mix well and set aside.
[0076] Step 5: Use a gravity chromatography column and fill it with ion exchange chromatography filler to obtain a gravity column; use 8-15 times the filler volume of ion exchange chromatography gravity column balance reagent LEB to balance the gravity column, and empty it naturally by gravity.
[0077] Among them, the ion exchange chromatography filler is a weakly basic anion exchange resin (Ultrapure 500, Qiagen); the filling volume of the ion exchange chromatography filler is determined according to the amount of plasmid preparation, plasmid preparation amount: filling volume of ion exchange chromatography filler = 100~180μg: 1ml; the specifications of the gravity chromatography column are matched with the filling volume of the ion exchange chromatography filler.
[0078] The ion exchange chromatography gravity column balance reagent LEB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water. The pH of the solution is 7.2±0.1. The molar concentration of NaCl in the solution is 1±0.1M, the molar concentration of MOPS is 50±5mM, the volume concentration of isopropanol is 15±1%, and the volume concentration of Triton X-114 is 0.5±0.1%.
[0079] Step 6. Transfer all the solutions obtained in step 4 into the gravity column in batches and drain them naturally by gravity. Use 8-15 times the volume of the filler volume of impurity cleaning reagent LWB to clean the gravity column and drain them naturally by gravity. Add endotoxin removal reagent LER to the impurity cleaning reagent LWB in advance, and the volume ratio is endotoxin removal reagent LER: impurity cleaning reagent LWB = 1±0.1:100. Mix well and place in an ice bath for use.
[0080] Among them, the impurity cleaning reagent LWB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, the pH of the solution is 7.2±0.1, the molar concentration of NaCl in the solution is 750±50mM, the molar concentration of MOPS is 50±5mM, the concentration of isopropanol is 15±1%, and the concentration of Triton X-114 is 0.15±0.02%.
[0081] The endotoxin removal reagent LER is the same as in step 4.
[0082] Step 7: Add 1.2-2 times the volume of the filler material of the plasmid elution reagent LEN to the gravity column for elution, and collect the eluate.
[0083] Among them, the plasmid elution reagent LEN is a solution composed of NaCl, MOPS, isopropanol and water, the pH of the solution is 7.2±0.1, the molar concentration of NaCl in the solution is 1.6±0.1M, the molar concentration of MOPS is 50±5mM, and the concentration of isopropanol is 15±1%.
[0084] Step 8. Add isopropanol to the eluent, and the volume ratio of eluent: isopropanol is 1±0.1:0.7, mix well and centrifuge; remove the supernatant, add 70±1% ethanol to rinse the precipitate, and the volume ratio of eluent: 70±1% ethanol is 1:1-2, and centrifuge.
[0085] Among them, isopropanol and 70±1% ethanol are pre-cooled to preset temperatures for use, and the preset temperatures are room temperature or 3°C~4°C; the mixing after adding isopropanol is performed by inversion mixing; the centrifugation conditions are 15000~16000×g, 30~40min, 3°C~4°C.
[0086] Step 9: Remove the supernatant, air-dry naturally until the edge of the precipitate becomes transparent, add a predetermined volume of endotoxin-free plasmid solvent to dissolve, and obtain a low-copy endotoxin-free plasmid solution.
[0087] The endotoxin-free plasmid solvent is endotoxin-free ddH2O or endotoxin-free TE buffer.
[0088] For the above reagents, bacterial lysis reagent L1 and bacterial lysis reagent L3 are stored at 3°C~4°C in advance, and the remaining reagents are stored at room temperature in advance.
[0089] The kit for preparing low-copy endotoxin-free plasmid specifically implemented by the present invention comprises the above-mentioned reagents and devices.
[0090] The present invention is further described in detail below by examples, including description of the principle of the present invention and the operation process. However, the present invention is not limited to the given examples, and these examples are not intended to limit the scope of the present invention.
[0091] In the following examples, the formula of the kanamycin-resistant plant-derived rich medium is: yeast extract (YE) 15 g / L, soy peptone (Soytone) 25 g / L, MgSO4 0.3 g / L, NaCl 5 g / L, glycerol (Glycerol) 10 g / L, Na2HPO4·12H2O 7 g / L, KH2PO4 2 g / L, 0.05 g / L kanamycin is added, and the balance is water.
[0092] In the first step of the specific implementation scheme of the present invention, when the volume of the E. coli culture solution is less than 200 ml, a 50 ml centrifuge tube is used for centrifugal collection, and when the volume of the E. coli culture solution is ≥ 200 ml, a 500 ml centrifuge bottle is used for centrifugal collection.
[0093] In the second step of the specific implementation scheme of the present invention, after adding the bacterial lysis reagent L1, when the volume of the Escherichia coli resuspension is less than 40 ml, it is evenly divided into multiple 50 ml centrifuge tubes to ensure that the volume in each tube does not exceed 10 ml. After adding the bacterial lysis reagent L2, tighten the tube cap and gently invert it 8-15 times until the mixed liquid is light yellow and translucent. After adding the bacterial lysis reagent L3, tighten the tube cap and gently invert it 8-15 times until the mixed sample is light yellow liquid with egg drop-shaped floating solids.
[0094] In the second step of the specific implementation scheme of the present invention, after adding the bacterial lysis reagent L1, when the volume of the Escherichia coli resuspension is 40-400 ml, it is evenly divided into multiple 500 ml centrifuge bottles to ensure that the volume in each tube does not exceed 100 ml. After adding the bacterial lysis reagent L2, tighten the tube cap, gently invert and rotate it in an eight-shaped shape for 8-15 times until the mixed liquid is light yellow and translucent. After adding the bacterial lysis reagent L3, tighten the tube cap, gently invert and rotate it in an eight-shaped shape for 8-15 times until the mixed sample is a light yellow liquid with egg drop-shaped floating solids.
[0095] In the second step of the specific implementation scheme of the present invention, after adding the bacterial lysis reagent L1, when the volume of the Escherichia coli resuspension is greater than 400 ml, the Escherichia coli resuspension and the bacterial lysis reagent L2 are poured into a beaker of appropriate volume at a uniform speed at the same time, and stirred at a speed of 30 rpm for 3-4 minutes using a stirrer or a glass rod until the mixed liquid is light yellow and translucent. After adding the bacterial lysis reagent L3, stir clockwise for 15 seconds with a stirrer or a glass rod at 30 rpm, and then stir counterclockwise for 15 seconds until the mixed sample is a light yellow liquid with egg drop-shaped floating solids.
[0096] In the seventh step of the specific implementation scheme of the present invention, when the added plasmid elution reagent LEN is less than 4 ml, a 1.5 ml EP tube is used to receive and evenly divide the amount, with each tube not exceeding 1 ml; when the added plasmid elution reagent LEN is greater than or equal to 4 ml, a 50 ml centrifuge tube is used to receive and evenly divide the amount, with each tube not exceeding 25 ml.
[0097] Example 1
[0098] This example is about the extraction of a small amount of plasmid of 100 μg.
[0099] The basic steps of this embodiment are consistent with the above specific technical solutions for implementing the present invention.
[0100] The plasmid involved in this embodiment contains a polyadenylation (poly (A)) sequence. The size of the plasmid is 6942 bp. The plasmid sequence is shown in SEQ ID No.1.
[0101] The specific contents of this embodiment are as follows:
[0102] 1. Inoculate the bacterial solution of Escherichia coli containing the above plasmid into 200 ml of kanamycin (KANA) resistant plant-derived rich culture medium at a ratio of 1‰, and culture at 30°C and 220rpm for 16 hours to obtain the Escherichia coli culture solution containing the plasmid.
[0103] 2. Transfer 150 ml of culture medium to a 500 ml centrifuge bottle, centrifuge at 8000 rpm, 5 min, 4 °C to enrich E. coli, remove the supernatant, quantify the bacterial weight to 2.4 g, add 36 ml of bacterial lysis reagent L1 (add RNase A in advance), resuspend thoroughly and divide equally into four 50 ml centrifuge tubes.
[0104] 3. Add 15 ml of bacterial lysis reagent L2 to each centrifuge tube, tighten the tube cap, gently invert 8-15 times until the liquid becomes light yellow and translucent, and let it stand for 3 minutes.
[0105] 4. Add 15 ml of bacterial lysis reagent L3 to each centrifuge tube, tighten the tube cap, and gently invert for 8-15 times until the sample is a light yellow liquid with egg drop-shaped floating solids. Pour the lysate into a small lysate filter device in batches for filtration to obtain about 150 ml of clarified lysate. Add 3 ml of endotoxin removal reagent LER, gently invert to mix, and place on ice for 30 minutes.
[0106] 5. Use a 6 ml gravity chromatography column to fill with 1 ml ion exchange chromatography filler (Ultrapure 500, Qiagen), pour 15 ml ion exchange chromatography gravity column balance reagent LEB into the balance gravity column in batches, and drain naturally by gravity.
[0107] 6. Transfer the clarified lysate obtained in step 4 in batches to the gravity column obtained in step 5, drain by gravity, use 15 ml of impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place in an ice bath) to clean the gravity column, and drain by gravity.
[0108] 7. Add 1.5 ml of plasmid elution reagent LEN for elution, collect the eluate, divide it equally into 2 1.5 ml centrifuge tubes, add 0.7 times the volume of the eluate pre-cooled isopropanol, gently invert to mix, and then centrifuge at 15000 × g, 30 min, 4 ° C.
[0109] 8. Remove the supernatant, add 750 μl of pre-cooled 70% ethanol to gently rinse the precipitate, and then centrifuge at 15,000 × g, 30 min, and 4°C.
[0110] 9. Remove the supernatant, air dry naturally until the edge of the precipitate is transparent, add endotoxin-free ddH2O to dissolve, combine, and dilute to 100μl, test A260 / 280, A260 / 230, calculate the plasmid concentration and total amount, and perform electrophoresis. At the same time, the endotoxin test adopts the bacterial endotoxin test method of 1143 of the Chinese Pharmacopoeia Part IV (2020 Edition), and detects 100EU / mg, 50EU / mg, and 20EU / mg respectively.
[0111] Example 2
[0112] This example is the extraction of 600 μg of a medium-sized plasmid.
[0113] The basic steps of this embodiment are consistent with the above specific technical solutions for implementing the present invention.
[0114] The plasmid involved in this embodiment contains a polyadenylation (poly (A)) sequence. The size of the plasmid is 9633 bp. The plasmid sequence is shown in SEQ ID No.2.
[0115] The specific contents of this embodiment are as follows:
[0116] 1. Inoculate the bacterial solution of Escherichia coli containing the above plasmid into 2×300 ml of kanamycin (KANA) resistant plant-derived rich culture medium at a ratio of 1‰, and culture at 30°C and 220rpm for 16 hours to obtain the Escherichia coli culture solution containing the plasmid.
[0117] 2. Transfer the culture medium to a 500 ml centrifuge bottle and centrifuge at 8000 rpm, 5 min, and 4 °C to enrich E. coli. Remove the supernatant and quantify the bacterial weight to be 3.6 g and 3.8 g, respectively. Add 57 ml of bacterial lysis reagent L1 (RNase A was added in advance) and resuspend thoroughly.
[0118] 3. Add 95 ml of bacterial lysis reagent L2 to each centrifuge bottle, tighten the tube cap, gently invert and rotate in a figure eight shape for 8-15 times until the liquid becomes light yellow and translucent, and let it stand for 3 minutes.
[0119] 4. Add 95 ml of bacterial lysis reagent L3 to each centrifuge bottle, tighten the tube cap, gently invert and rotate in a figure eight shape for 8-15 times until the sample is a light yellow liquid with egg drop-shaped floating solids. Use a medium-volume lysis solution filter to filter and obtain about 500 ml of clear lysis solution. Add 25 ml of endotoxin removal reagent LER, gently invert to mix, and then ice bath for 30 minutes.
[0120] 5. Use a 30 ml gravity chromatography column to fill with 5 ml ion exchange chromatography filler (Ultrapure 500, Qiagen), pour 75 ml ion exchange chromatography gravity column balance reagent LEB into the balance gravity column in batches, and drain naturally by gravity.
[0121] 6. Transfer the clarified lysate obtained in step 4 in batches to the gravity column obtained in step 5, drain it naturally by gravity, use 75 ml of impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place on ice) to clean the gravity column, and drain it naturally by gravity.
[0122] 7. Add 10 ml of plasmid elution reagent LEN for elution, collect the eluate, add 0.7 times the volume of the eluate, add pre-cooled isopropanol, gently invert to mix, and then centrifuge at 15000×g, 30 min, and 4°C.
[0123] 8. Remove the supernatant, add 10 ml of pre-cooled 70% ethanol to gently rinse the precipitate, and then centrifuge at 15,000 × g, 30 min, 4°C.
[0124] 9. Remove the supernatant, air dry naturally until the edge of the precipitate is transparent, add endotoxin-free ddH2O to dissolve, combine, and adjust the volume to 600μl, detect A260 / 280, A260 / 230, calculate the plasmid concentration and total amount, and perform electrophoresis detection. At the same time, the endotoxin test adopts the bacterial endotoxin test method of 1143 of the Chinese Pharmacopoeia Part IV (2020 Edition), and detects 100EU / mg, 50EU / mg, and 20EU / mg respectively.
[0125] Example 3
[0126] This example is about the extraction of a large amount of plasmid, 5 mg.
[0127] The basic steps of this embodiment are consistent with the above specific technical solutions for implementing the present invention.
[0128] The plasmid involved in this embodiment contains a polyadenylation (poly (A)) sequence. The size of the plasmid is 7005 bp. The plasmid sequence is shown in SEQ ID No.3.
[0129] The specific contents of this embodiment are as follows:
[0130] 1. Inoculate the bacterial solution of Escherichia coli containing the above plasmid into 8×400 ml of kanamycin (KANA) resistant plant-derived rich culture medium at a ratio of 1‰, and culture at 30°C and 220rpm for 16 hours to obtain the Escherichia coli culture solution containing the plasmid.
[0131] 2. Transfer the culture medium to several 500ml centrifuge bottles, centrifuge at 8000rpm, 5min, 4℃ to enrich E. coli, remove the supernatant, and quantify the total bacterial weight of 65.6g. Add 125ml of bacterial lysis reagent L1 (add RNaseA in advance) to each bottle, resuspend thoroughly and pour into a 2L plastic beaker.
[0132] 3. Pour the E. coli resuspension obtained in step 2 and 1640 ml of bacterial lysis reagent L2 into a 5L plastic beaker at a uniform speed at the same time, stir with a glass rod at a speed of 30 rpm for 3-4 minutes, and the liquid will be light yellow and translucent.
[0133] 4. Add 1640 ml of bacterial lysis reagent L3 to a plastic beaker, stir with a glass rod clockwise at 30 rpm for 15 seconds, then counterclockwise for 15 seconds. The sample should be a light yellow liquid with egg-drop-shaped floating solids. Use a large number of lysis liquid filtration devices to filter and obtain about 4.2 L of clear lysis liquid. Add 84 ml of endotoxin removal reagent LER, gently invert to mix, and place in an ice bath for 30 minutes.
[0134] 5. Use a 150 ml gravity chromatography column to fill 35 ml of ion exchange chromatography filler (Ultrapure 500, Qiagen), pour 500 ml of ion exchange chromatography gravity column balance reagent LEB into the gravity column in batches, and drain naturally by gravity.
[0135] 6. Transfer the clarified lysate obtained in step 4 in batches to the gravity column obtained in step 5, drain by gravity, use 525 ml of impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place in an ice bath) to clean the gravity column, and drain by gravity.
[0136] 7. Add 50 ml of plasmid elution reagent LEN for elution, collect the eluate, divide it equally into two 50 ml centrifuge tubes, add 0.7 times the volume of the eluate pre-cooled isopropanol, gently invert to mix, and centrifuge at 15000 × g, 30 min, 4 ° C.
[0137] 8. Remove the supernatant, add 25 ml of pre-cooled 70% ethanol to gently rinse the precipitate, and then centrifuge at 15,000 × g, 30 min, and 4°C.
[0138] 9. Remove the supernatant, air dry naturally until the edge of the precipitate is transparent, add endotoxin-free ddH2O to dissolve, combine, and adjust the volume to 5 ml, test A260 / 280, A260 / 230, calculate the plasmid concentration and total amount, and perform electrophoresis. At the same time, the endotoxin test adopts the bacterial endotoxin test method of 1143 of the Chinese Pharmacopoeia Part IV (2020 Edition), and detects 100EU / mg, 50EU / mg, and 20EU / mg respectively.
[0139] For the above Examples 1 to 3, the results of the bacterial weight, plasmid purity and concentration tests are shown in Table 1. The results of the plasmid electrophoresis test are shown in Table 1. Figure 1 The results of plasmid endotoxin detection are shown in Table 2.
[0140] Table 1. Test results of bacterial weight, plasmid purity and concentration
[0141]
[0142] Table 2. Plasmid endotoxin detection results
[0143]
[0144] From the above results, it can be seen that Examples 1 to 3 use the method of the present invention to prepare low-copy endotoxin-free plasmids, which not only has high extraction efficiency and can meet the demand for low-copy plasmid preparation, but also has good endotoxin removal effect, which can make the plasmid endotoxin level reach below 20EU / mg, thereby meeting the requirement of endotoxin <100EU / mg.
[0145] Example 4
[0146] This example compares the preparation method of the present invention with the existing kit preparation method.
[0147] The existing kit used in this example is: EndoFree Plasmid Maxi Kit produced by QIAGEN, with a catalog number of 12362; which contains: buffer P1, buffer P2, buffer P3, buffer ER, buffer QBT, buffer QC, buffer QN, a dedicated filter component (QIAfilter MaxiCartridge), and a chromatography column (QIAGEN-tip 500). Note: The specific description and instructions for use of the kit can be found on the QIAGEN official website.
[0148] The plasmid involved in this embodiment contains a polyadenylation (poly (A)) sequence. The size of the plasmid is 4625 bp. The plasmid sequence is shown in SEQ ID No.4.
[0149] The specific contents of this embodiment are as follows:
[0150] 1. Inoculate the bacterial solution of Escherichia coli containing the above plasmid into 3×250 ml of kanamycin (KANA) resistant plant-derived rich culture medium at a ratio of 1‰, and culture at 30°C and 220rpm for 16 hours to obtain the Escherichia coli culture solution containing the plasmid.
[0151] 2. The culture solution was evenly divided into two 500 ml centrifuge bottles, centrifuged at 8000 rpm, 5 min, 4 ° C to enrich E. coli, and the supernatant was removed. The total quantitative bacterial weight was 8.1 g, and the culture solution was evenly divided into three groups: Q1, Q2, and L. Among them, the Q1 group was prepared entirely by the above-mentioned existing kit method, the Q2 group was prepared by the first half of the method of the present invention and the second half of the above-mentioned existing kit method, and the L group was prepared entirely by the method of the present invention.
[0152] 3. This step uses the reagents and components of the existing kit to perform the operation, specifically: add 10 ml of buffer P1 (RNase A has been added), 10 ml of buffer P2 and 10 ml of buffer P3 to the Q1 group sample in sequence, let it stand according to the instructions for use of the kit, and filter it using its dedicated filter component (QIAfilter Maxi Cartridge) to obtain 30 ml of clarified lysate, add 2.5 ml of buffer ER, gently invert and mix, and then ice-bathe for 30 minutes; obtain the Q1 group lysate.
[0153] 4. This step adopts the reagents and components of the present invention for operation, specifically: add 40 ml of bacterial lysis reagent L1 (RNaseA is added in advance) to the samples of group Q2 and group L respectively, and divide them equally into four 50 ml centrifuge tubes after sufficient resuspending, add 17 ml of bacterial lysis reagent L2 to each centrifuge tube, tighten the tube cover, gently invert 8-15 times, until the liquid is light yellow and translucent, let it stand for 3 minutes, add 17 ml of bacterial lysis reagent L3 to each centrifuge tube, tighten the tube cover, and gently invert 8-15 times until the sample is light yellow liquid with egg drop-shaped floating solids, pour the lysate into a small amount of lysate filter device in batches for filtration, and obtain about 170 ml of clarified lysate, add 3.4 ml of endotoxin removal reagent LER, gently invert and mix, and then ice bath for 30 minutes; obtain Q2 group lysate and L group lysate.
[0154] 5. This step is performed using the gravity column of the present invention, specifically: a 30 ml gravity chromatography column is filled with 2 ml ion exchange chromatography filler (Ultrapure 500, Qiagen), 60 ml ion exchange chromatography gravity column balance reagent LEB is poured into the balanced gravity column in batches, and the column is emptied naturally by gravity to obtain an L gravity column for subsequent filtration of the L group lysate.
[0155] 6. This step uses the chromatography column (QIAGEN-tip 500) of the existing kit for operation. Specifically, take two chromatography columns, add 10 ml of buffer QBT to each column, and drain by gravity to obtain Q1 gravity column and Q2 gravity column, which are used for subsequent filtration of Q1 group and Q2 group lysate.
[0156] 7. Transfer the lysate of group Q1 to the Q1 gravity column several times and let it drain naturally by gravity; transfer the lysate of group Q2 to the Q2 gravity column several times and let it drain naturally by gravity; transfer the lysate of group L to the L gravity column several times and let it drain naturally by gravity.
[0157] 8. Pour 2×30ml buffer QC into the Q1 gravity column in batches and drain it naturally by gravity; add 75ml impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place in an ice bath) into the Q2 gravity column in batches to clean the gravity column and drain it naturally by gravity; add 60ml impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place in an ice bath) into the L gravity column in batches to clean the gravity column and drain it naturally by gravity.
[0158] 9. Add 15 ml of buffer QN to the Q1 gravity column for elution and collect the eluate; add 15 ml of plasmid elution reagent LEN to the Q2 gravity column and L gravity column for elution and collect the eluate; add 0.7 times the volume of pre-cooled isopropanol to each group of eluate, gently invert to mix, and then centrifuge at 15000×g, 30 min, 4°C.
[0159] 10. Remove the supernatant from each group of samples, add 25 ml of pre-cooled 70% ethanol to gently rinse the precipitate, and then centrifuge at 15,000×g, 30 min, and 4°C.
[0160] 11. Remove the supernatant from each group of samples, air-dry naturally until the edge of the precipitate is transparent, add endotoxin-free ddH2O to dissolve, combine, and adjust the volume to 500μl, detect A260 / 280 and A260 / 230, calculate the plasmid concentration and total amount, and perform electrophoresis detection. At the same time, the endotoxin test adopts the bacterial endotoxin test method of 1143 of the Chinese Pharmacopoeia Part IV (2020 Edition), and detects 100EU / mg, 50EU / mg, and 20EU / mg respectively.
[0161] The results of the bacterial weight, plasmid purity and concentration test in this example are shown in Table 3, and the results of the plasmid electrophoresis test are shown in Table 3. Figure 2 The results of plasmid endotoxin detection are shown in Table 4.
[0162] Table 3. Test results of bacterial weight, plasmid purity and concentration
[0163]
[0164] Table 4. Plasmid endotoxin detection results
[0165]
[0166] From the above results, it can be seen that the Q1 group plasmid product prepared entirely by the above-mentioned existing kit method has the problems of abnormal OD and extremely high endotoxin, which may be caused by the low plasmid copy number, resulting in a significant reduction in RNA removal efficiency and endotoxin removal efficiency. In comparison, the Q2 group plasmid product prepared by the first half of the method of the present invention and the second half of the above-mentioned existing kit method has a higher preparation amount, normal OD, and endotoxin level of 20EU / mg; at the same time, the L group plasmid product prepared entirely by the method of the present invention has a higher preparation amount, normal OD, and endotoxin level <20EU / mg. From the above comparison, it can be seen that for low-copy plasmids, the technical solution of the present invention can well overcome the problems of abnormal OD and extremely high endotoxin in the above-mentioned existing kits, and achieve the excellent effect of high preparation amount and low endotoxin level.
[0167] Example 5
[0168] This example compares the preparation method of the present invention with the existing kit preparation method.
[0169] The existing kit used in this embodiment is the same as that in Example 4.
[0170] The plasmid involved in this embodiment contains a polyadenylation (poly (A)) sequence. The size of the plasmid is 5375 bp. The plasmid sequence is shown in SEQ ID No.5.
[0171] The previous embodiments all adopted the method of inoculating bacterial liquid into culture medium for cultivation. Since the copy number of plasmid containing polyadenylation (poly(A)) sequence is too low, in order to simulate the extraction of plasmid with normal copy number, this embodiment uses wet bacterial mud obtained by fermentation to conduct experiments and compare and verify the endotoxin removal effect.
[0172] The specific contents of this embodiment are as follows:
[0173] 1. The wet bacteria of Escherichia coli containing the above-mentioned plasmid were obtained by fermentation in a fermenter, and the fermentation bacteria yield was 2.4 mg / g. 1 g of wet bacteria was used for the subsequent two experimental groups, named Q-ER group and L-ER group.
[0174] 2. This step uses the reagents and components of the existing kit to perform the operation, specifically: add 10 ml of buffer P1 (RNase A has been added), 10 ml of buffer P2, and 10 ml of buffer P3 to the Q-ER group sample in sequence, let it stand according to the instructions for use of the kit, and filter it using its dedicated filter component (QIAfilter Maxi Cartridge) to obtain 30 ml of clarified lysate, add 2.5 ml of buffer ER, gently invert and mix, and then place on ice for 30 minutes; obtain the Q1 group lysate.
[0175] 3. This step is performed using the reagents and components of the present invention, specifically: 15 ml of bacterial lysis reagent L1 (RNaseA is added in advance) is added to the L-ER group sample, and the mixture is evenly divided into two 50 ml centrifuge tubes after being fully resuspended, 12.5 ml of bacterial lysis reagent L2 is added to each centrifuge tube, the tube cap is tightened, and the mixture is gently inverted for 8-15 times until the liquid is light yellow and translucent, and the mixture is allowed to stand for 3 minutes, 12.5 ml of bacterial lysis reagent L3 is added to each centrifuge tube, the tube cap is tightened, and the mixture is gently inverted for 8-15 times until the sample is light yellow liquid with egg drop-shaped floating solids, the lysate is poured into a small amount of lysate filter device in batches for filtration to obtain about 65 ml of clarified lysate, 1.3 ml of endotoxin removal reagent LER is added, the mixture is gently inverted and mixed, and then ice-bathed for 30 minutes; the L-ER group lysate is obtained.
[0176] 4. On the one hand, the gravity column of the present invention is used for operation, specifically: 5 ml of ion exchange chromatography filler (Ultrapure 500, Qiagen) is filled into a 30 ml gravity chromatography column, 75 ml of ion exchange chromatography gravity column balance reagent LEB is poured into the balanced gravity column in batches, and the column is emptied naturally by gravity to obtain an L-ER gravity column for subsequent filtration of the L-ER group lysate.
[0177] On the other hand, the chromatography column (QIAGEN-tip 500) of the existing kit was used for the operation, specifically: 10 ml of buffer QBT was added to the chromatography column, and gravity was used to drain it naturally to obtain a Q-ER gravity column, which was used for the subsequent filtration of the Q-ER group lysate.
[0178] 5. Transfer the lysate of the Q-ER group to the Q-ER gravity column several times and drain it naturally by gravity; transfer the lysate of the L-ER group to the L-ER gravity column several times and drain it naturally by gravity.
[0179] 6. Pour 2×30 ml of buffer QC into the Q-ER gravity column in batches and drain it naturally by gravity; add 75 ml of impurity cleaning reagent LWB (add 1 / 100 volume of endotoxin removal reagent LER in advance, mix well and place in an ice bath) into the L-ER gravity column in batches to clean the gravity column and drain it naturally by gravity.
[0180] 7. Add 15 ml of buffer QN to the Q-ER gravity column for elution and collect the eluate; add 15 ml of plasmid elution reagent LEN to the L-ER gravity column for elution and collect the eluate; add 0.7 times the volume of pre-cooled isopropanol to each group of eluate, gently invert to mix, and then centrifuge at 15000×g, 30 min, 4℃.
[0181] 8. Remove the supernatant from each group of samples, add 25 ml of pre-cooled 70% ethanol to gently rinse the precipitate, and then centrifuge at 15,000 × g, 30 min, and 4°C.
[0182] 9. Remove the supernatant from each group of samples, air-dry naturally until the edge of the precipitate is transparent, add endotoxin-free ddH2O to dissolve, combine, and adjust the volume to 500μl, detect A260 / 280 and A260 / 230, calculate the plasmid concentration and total amount, and perform electrophoresis detection. At the same time, the endotoxin test adopts the bacterial endotoxin test method of 1143 of the Chinese Pharmacopoeia Part IV (2020 Edition), and detects 50EU / mg, 20EU / mg, and 10EU / mg respectively.
[0183] The plasmid endotoxin detection results of this example are shown in Table 5.
[0184] Table 5. Plasmid endotoxin detection results
[0185]
[0186] From the above results, it can be seen that for low-copy plasmids with high yields after fermentation, the Q-ER group prepared entirely by the above-mentioned existing kit method can reduce the plasmid endotoxin level to 20EU / mg, while the L-ER group prepared entirely by the method of the present invention can reduce the plasmid endotoxin level to below 10EU / mg, which obviously has a better endotoxin removal effect.
[0187] Based on the above embodiments:
[0188] (1) The present invention determines the dosage of each bacterial lysis reagent and the dosage of RNaseA therein according to the bacterial weight, thereby ensuring the lysis efficiency at a plasmid preparation amount of 20 μg-10 mg, thereby ensuring extremely low RNA and genome contamination; at the same time, the present invention has no restrictions on bacterial weight and culture amount, and can ensure the preparation amount of low-copy plasmid.
[0189] (2) The present invention specifies corresponding specifications of lysate filtration devices, corresponding ion exchange chromatography filler filling volumes, and matching specifications of gravity columns for different preparation quantities, ensuring that even low-copy plasmids can meet the extraction quantity.
[0190] (3) The present invention adds the endotoxin removal reagent LER to the clarified lysis solution and the impurity cleaning reagent LWB at the same time, thereby stably ensuring that even if the plasmid is low in copy number, the endotoxin is less than 100 EU / mg when the plasmid preparation amount is met.
[0191] The present invention uses resuspension, lysis, neutralization, clarification and washing as main steps, and can overcome the problems of extremely low extraction volume, drastically reduced endotoxin removal effect, genome contamination, plasmid A260 / 280 and A260 / 230 abnormalities, etc. in the existing technical methods for preparing low-copy plasmids, and achieves the technical effects of normal OD, high preparation volume and low endotoxin level, and is particularly suitable for preparing 20μg-10mg low-copy endotoxin-free plasmids.
[0192] In addition to the above embodiments, the present invention may also have other implementation modes. Any technical solution formed by equivalent replacement or equivalent transformation falls within the protection scope required by the present invention.
Claims
1. A method for preparing a low-copy endotoxin-free plasmid, Its characteristics are: The following steps are involved: The first step is to culture the bacteria containing the target low-copy plasmid to obtain a bacterial culture solution, and collect the bacterial cells by centrifugation; Wherein, the bacteria is Escherichia coli; the target low-copy plasmid contains a polyadenylation sequence and / or a low-copy replicon; the centrifugation conditions are 8000-9000 rpm, 5-6 min, and 3° C.-4° C.; Step 2: Weigh the weight of the bacteria, and determine the volumes of the bacteria lysis reagents L1, L2, and L3 according to the weight-to-volume ratio of bacteria: bacteria lysis reagent L1: bacteria lysis reagent L2: bacteria lysis reagent L3 = 1±0.1g:15ml:25ml:25ml; add the bacteria lysis reagent L1 to the bacteria and resuspend; add the bacteria lysis reagent L2, continue mixing until the mixed liquid is light yellow and translucent, and let it stand; add the bacteria lysis reagent L3, continue mixing until the mixed sample is a light yellow liquid with egg drop-shaped floating solids; wherein, the bacteria lysis reagent L1 is a solution composed of Tris-HCl, EDTA, glucose, RNaseA and water; the bacteria lysis reagent L2 is a solution composed of NaOH, SDS and water; the bacteria lysis reagent L3 is a solution composed of potassium acetate, acetic acid and water; Among them, in the bacterial lysis reagent L1, the molar concentration of Tris-HCl is 50±5mM, the molar concentration of EDTA is 10±1mM, the molar concentration of glucose is 25±2mM, and the concentration of RNaseA is 0.15±0.01g / L; in the bacterial lysis reagent L2, the molar concentration of NaOH is 0.2±0.02M, and the concentration of SDS is 1±0.1%; in the bacterial lysis reagent L3, the molar concentration of potassium acetate is 3±0.3M, and acetic acid is used to adjust the pH of the solution to 5.2~5.5; Step 3: Filter the mixture obtained in the second step using a lysate filtering device to obtain a clear and transparent lysate; the lysate filtering device is provided with a filter membrane or filter with a pore size of 0.45-10 μm; Step 4: Add endotoxin removal reagent LER to the lysate obtained in step 3, and the volume ratio of endotoxin removal reagent LER: lysate is 1±0.1:50; mix well and place in an ice bath until the solution is clear; wherein, the endotoxin removal reagent LER is a solution composed of Triton X-114 and ethanol in a volume ratio of 1±0.1:1; Step 5: Use a gravity chromatography column and fill it with ion exchange chromatography filler to obtain a gravity column; use 8-15 times the filler volume of ion exchange chromatography gravity column balance reagent LEB to balance the gravity column, and empty it naturally by gravity; wherein the ion exchange chromatography gravity column balance reagent LEB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; The ion exchange chromatography filler is a weakly basic anion exchange resin; the filling volume of the ion exchange chromatography filler is determined according to the amount of plasmid preparation, plasmid preparation amount: filling volume of ion exchange chromatography filler = 100~180μg: 1 ml; the specifications of the gravity chromatography column match the filling volume of the ion exchange chromatography filler; In the ion exchange chromatography gravity column balance reagent LEB, the molar concentration of NaCl is 1±0.1M, the molar concentration of MOPS is 50±5mM, the volume concentration of isopropanol is 15±1%, and the volume concentration of Triton X-114 is 0.5±0.1%; Step 6. Transfer all the solutions obtained in step 4 into the gravity column in batches, drain them naturally by gravity, use 8-15 times the volume of the filler volume of the impurity cleaning reagent LWB to clean the gravity column, and drain them naturally by gravity; add endotoxin removal reagent LER to the impurity cleaning reagent LWB in advance, and the volume ratio is endotoxin removal reagent LER: impurity cleaning reagent LWB = 1±0.1:100, mix well and put in an ice bath for use; wherein, the impurity cleaning reagent LWB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; in the impurity cleaning reagent LWB, the molar concentration of NaCl is 750±50mM, the molar concentration of MOPS is 50±5mM, the concentration of isopropanol is 15±1%, and the concentration of Triton X-114 is 0.15±0.02%; Step 7: Add 1.2-2 times the volume of the filler to the gravity column for elution with a plasmid elution reagent LEN, and collect the eluate; wherein the plasmid elution reagent LEN is a solution composed of NaCl, MOPS, isopropanol and water, and the pH of the solution is 7.2±0.1; in the plasmid elution reagent LEN, the molar concentration of NaCl is 1.6±0.1M, the molar concentration of MOPS is 50±5mM, and the concentration of isopropanol is 15±1%; Step 8: Add isopropanol to the eluate, and the volume ratio of the eluate: isopropanol is 1±0.1:0.7, mix well and centrifuge; remove the supernatant, add 70±1% ethanol to rinse the precipitate, and the volume ratio of the eluate: 70±1% ethanol is 1:1-2, and centrifuge; Step 9: Remove the supernatant, air-dry naturally until the edge of the precipitate is transparent, and add a predetermined volume of endotoxin-free plasmid solvent to dissolve, thereby obtaining a low-copy endotoxin-free plasmid solution; wherein, the endotoxin-free plasmid solvent is endotoxin-free ddH 2 O, or endotoxin-free TE buffer.
2. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, characterized in that, in the first step, the target low-copy plasmid also contains an antibiotic resistance gene, and a culture medium containing corresponding antibiotics is used during cultivation, and the culture medium is a plant-derived rich culture medium, and its components are: yeast extract 15g / L, soy peptone 25g / L, MgSO 4 0.3g / L, NaCl 5 g / L, glycerol 10g / L, Na 2 HPO 4 12H 2 O 7g / L, KH 2 PO 4 2g / L, add 0.05g / L corresponding antibiotic, and the rest is water.
3. The method for preparing a low-copy endotoxin-free plasmid according to claim 2, Its characteristics are: The specific process of the first step is: pick a single colony of Escherichia coli containing the target low-copy plasmid and inoculate it into 3~6 ml of a plant-derived rich culture medium containing the corresponding antibiotics, culture it at 30℃±1℃ 200±20rpm until OD600 is 2±0.2, inoculate it into 400~500 ml of a plant-derived rich culture medium containing the corresponding antibiotics at a ratio of 1‰, culture it at 30℃±1℃ 200±20rpm for 12~24h to obtain a bacterial culture solution; centrifuge at 8000~9000rpm, 5~6min, 3℃~4℃ to collect the Escherichia coli cells.
4. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, Its characteristics are: In the second step, continuous mixing is performed by inversion mixing or continuous stirring at 30-40 rpm.
5. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, Its characteristics are: In the third step, the lysate filtering device includes a small amount of lysate filtering device, a medium amount of lysate filtering device, and a large amount of lysate filtering device; The small amount lysate filtering device comprises a 30ml syringe and a matching piston rod, a 1μm syringe filter connected to the syringe outlet is arranged outside the syringe, and a 50μm pore size PP material baffle, a 5μm pore size PP material filter membrane, a 10μm pore size PP material filter membrane, and a 50μm pore size PP material baffle are arranged near the outlet of the syringe in sequence, wherein the 5μm pore size PP material filter membrane is closer to the syringe outlet than the 10μm pore size PP material filter membrane, the diameter of the PP material baffle is 23mm, and the diameter of the PP material filter membrane is 22.5mm; The medium-volume lysate filtering device comprises a diaphragm vacuum pump and a 500 ml vacuum filter, wherein a PES membrane with a pore size of 0.45 μm is arranged in the vacuum filter; A large number of lysate filtration devices include a PP capsule filter with a pore size of 1 μm, a peristaltic pump, and a pressure gauge; When the volume of the mixture obtained in the second step is less than 200 ml, a small amount of lysate filtering device is used; when 200 ml ≤ the volume of the mixture obtained in the second step ≤ 500 ml, a medium amount of lysate filtering device is used; when the volume of the mixture obtained in the second step is greater than 500 ml, a large amount of lysate filtering device is used.
6. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, Its characteristics are: In the fourth step, mix as needed during ice bath. If the ice bath cannot clarify the solution, centrifuge the solution at 15,000-16,000 × g, 10-20 min, 3°C-4°C, take the supernatant and add endotoxin removal reagent LER. The volume ratio of endotoxin removal reagent LER added here: the lysate obtained in the third step is 1±0.1:
50. Mix well and set aside.
7. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, Its characteristics are: In the eighth step, isopropanol and 70±1% ethanol are precooled to preset temperatures for use, respectively, and the preset temperature is room temperature or 3°C~4°C; the mixing after adding isopropanol is performed by inversion mixing; the centrifugation conditions are 15000~16000×g, 30~40min, 3°C~4°C.
8. The method for preparing a low-copy endotoxin-free plasmid according to claim 1, Its characteristics are: Bacteria lysis reagent L1 and bacteria lysis reagent L3 are stored at 3°C~4°C in advance for use, and bacteria lysis reagent L2, endotoxin removal reagent LER, ion exchange chromatography gravity column balance reagent LEB, impurity cleaning reagent LWB, plasmid elution reagent LEN, and endotoxin-free plasmid solvent are stored at room temperature for use.
9. A kit for preparing a low-copy endotoxin-free plasmid, Its characteristics are: The method for preparing a low-copy endotoxin-free plasmid according to any one of claims 1 to 8 is used as a use process, and the kit comprises: a bacterial lysis reagent L1, a bacterial lysis reagent L2, a bacterial lysis reagent L3, an endotoxin removal reagent LER, an ion exchange chromatography gravity column balance reagent LEB, an impurity cleaning reagent LWB, a plasmid elution reagent LEN, a lysis solution filter, a gravity chromatography column, and an ion exchange chromatography filler; Among them, the bacterial lysis reagent L1 is a solution composed of Tris-HCl, EDTA, glucose, RNaseA and water; the bacterial lysis reagent L2 is a solution composed of NaOH, SDS and water; the bacterial lysis reagent L3 is a solution composed of potassium acetate, acetic acid and water; the endotoxin removal reagent LER is a solution composed of Triton X-114 and ethanol in a volume ratio of 1±0.1:1; the ion exchange chromatography gravity column balance reagent LEB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; the impurity cleaning reagent LWB is a solution composed of NaCl, MOPS, isopropanol, Triton X-114 and water, and the pH of the solution is 7.2±0.1; the plasmid elution reagent LEN is a solution composed of NaCl, MOPS, isopropanol and water, and the pH of the solution is 7.2±0.1; the lysate filtration device is provided with a filter membrane or filter with a pore size of 0.45~10μm; In the bacterial lysis reagent L1, the molar concentration of Tris-HCl is 50±5mM, the molar concentration of EDTA is 10±1mM, the molar concentration of glucose is 25±2mM, and the concentration of RNaseA is 0.15±0.01g / L; in the bacterial lysis reagent L2, the molar concentration of NaOH is 0.2±0.02M, and the concentration of SDS is 1±0.1%; in the bacterial lysis reagent L3, the molar concentration of potassium acetate is 3±0.3M, and acetic acid is used to adjust the pH of the solution to 5.2~5.5; in the ion exchange chromatography gravity column balance reagent LEB, the molar concentration of NaCl is 1±0.1M, the molar concentration of MOPS is 50±5mM, the volume concentration of isopropanol is 15±1%, and the volume concentration of Triton is 1. The volume concentration of X-114 is 0.5±0.1%; in the impurity cleaning reagent LWB, the molar concentration of NaCl is 750±50mM, the molar concentration of MOPS is 50±5mM, the concentration of isopropanol is 15±1%, and the concentration of Triton X-114 is 0.15±0.02%; in the plasmid elution reagent LEN, the molar concentration of NaCl is 1.6±0.1M, the molar concentration of MOPS is 50±5mM, and the concentration of isopropanol is 15±1%; The ion exchange chromatography filler is a weakly basic anion exchange resin. The filling volume of the ion exchange chromatography filler is determined according to the amount of plasmid preparation. The amount of plasmid preparation: the filling volume of the ion exchange chromatography filler = 100~180μg: 1 ml; the specifications of the gravity chromatography column match the filling volume of the ion exchange chromatography filler.
10. A kit for preparing a low-copy endotoxin-free plasmid according to claim 9, Its characteristics are: The lysate filtering device includes a small amount lysate filtering device, a medium amount lysate filtering device, and a large amount lysate filtering device; The small amount lysate filtering device comprises a 30ml syringe and a matching piston rod, a 1μm syringe filter connected to the syringe outlet is arranged outside the syringe, and a 50μm pore size PP material baffle, a 5μm pore size PP material filter membrane, a 10μm pore size PP material filter membrane, and a 50μm pore size PP material baffle are arranged near the outlet of the syringe in sequence, wherein the 5μm pore size PP material filter membrane is closer to the syringe outlet than the 10μm pore size PP material filter membrane, the diameter of the PP material baffle is 23mm, and the diameter of the PP material filter membrane is 22.5mm; The medium-volume lysate filtering device comprises a diaphragm vacuum pump and a 500 ml vacuum filter, wherein a PES membrane with a pore size of 0.45 μm is arranged in the vacuum filter; A large number of lysate filtration devices include a PP capsule filter with a pore size of 1 μm, a peristaltic pump, and a pressure gauge; When the lysate volume is less than 200 ml, a small-volume lysate filtration device is used; when 200 ml ≤ lysate volume ≤ 500 ml, a medium-volume lysate filtration device is used; when the lysate volume is greater than 500 ml, a large-volume lysate filtration device is used.
